Cambridge, UK, 16th April 2021 We are delighted to announce that Sunil Shah of o2h ventures has won the prestigious award at the Cambridge Independent Science and Technology Awards as CEO of the Year.
Sunil and his brother (co-founder) Prashant have been building the Anglo-India o2h Group together since 2003. They have built a scientifically driven ecosystem of ~350 people to support and invest into early stage therapeutic, AI driven biotech companies. The o2h Group has research infrastructure and investments in Cambridge, UK and Ahmedabad, India with collaborations across three continents.
In Cambridge UK, o2h Group has been developing the newly named “Mill SciTech Park’ a 2.7 Acre plot, to the south of Cambridge with close connections to the other science parks, Addenbrooke’s Hospital and Astrazeneca HQ. This site will allow o2h Ventures to invest and support companies as they form from its ‘Human Health SEIS Fund’ with the aim to build two ‘homegrown’ biotech companies per year.
The flagship Human Health EIS Fund is now in its 2nd full year and has been followed with the launch of the first HMRC approved Knowledge Intensive fund and together with earlier Angel investments made by the brothers investments have been made in over 30 fledgling biotech companies many of which are based in Cambridge, including Exonate, Small Pharma, Arecor, Phoremost, Talisman, Spirea, Sentinel Oncology, Acacia, AI Vivo, Turbine, PharmEnable, Somaserve and Stemnovate.
Sunil is a serial entrepreneur having begun his career in the Life Sciences team at Cambridge based PA Consulting group followed by an MBA at Cambridge University. He has a passion for biotech, company creation and investing and he is on the board at Cambridge Angels, the Biotech Industry Association (BIA), as well as Chair/Board/Observer of Exonate, Metrion, In4Derm, Stingray Bio, Kuano and Oxford Drug Design. He is the UKBAA 2019/20 Angel of the Year and won the ‘Special Recognition Award’ at the biotech industry leading OBN Awards 2019.
Sunil Shah, said “I am honored to win this award and accept this on behalf of both Prashant and I. We are both hugely passionate entrepreneurs and love innovating and building. I still feel that we are the beginning of our journey and have big plans to continue our journey of company creation, investing and providing support to the biotech companies that we work with. We are very excited to open our doors at the Mill SciTech Park and continue our vision to build the most vibrant ecosystem to support early stage biotech companies. ”
About Cambridge Independent
The Cambridge Independent is an award-winning weekly newspaper and website published by Iliffe Media Ltd. It was first established as a newspaper in 1815 and was published until 1981. They aim to reflect the interests, concerns and views of the people who live here by creating distinctive, intelligent editorial, while offering effective advertising solutions. The team also writes, designs and prints niche publications to serve the community.
About the Science and Technology Awards
The prestigious Science and Technology Awards are organised by the Cambridge Independent. With 15 categories for companies and individuals, last year’s awards promise another celebration of the Cambridge region’s extraordinary talent. The awards are now in their fourth year and have grown dramatically since their inception. They witnessed a celebration of the extraordinary. Innovation, ingenuity and exceptional talent were on display across 14 panels.
An independent judging panel, chaired by Cambridge Independent editor Paul Brackley, had the challenging task of examining well over 100 nominees to determine the winners and the highly commended entries.
A virtual ceremony, taking place in a bespoke interactive environment, was attended by leaders of businesses, organisations and research institutes across the Cambridge region.
About o2h Group
The o2h Group has two sites in Cambridge, UK and Ahmedabad, India and is made-up of three teams: o2h Ventures, o2h Discovery, and o2h Technology. The teams work together to support and invest into early stage biotech therapeutic companies and AI.
For more information about o2h ventures , please visit www.o2hventures.com
Media Contact : Ajit Singh
Marketing and PR, o2h ventures Ltd